The pharmaceutical industry argues that lower prices will have catastrophic effects on research and development, while other suggest that curbing drug prices will result in only modest cuts in the ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

A new study from the Tippie College of Business finds that many drug prices actually drop after pharmaceutical company ...

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

A new poll shows an overhwhelming majority of Marylanders believe drug makers could reduce costs for prescription drugs ...

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...